These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
260 related articles for article (PubMed ID: 37400829)
1. Differential expression of the circadian clock network correlates with tumour progression in gliomas. Petkovic M; Yalçin M; Heese O; Relógio A BMC Med Genomics; 2023 Jul; 16(1):154. PubMed ID: 37400829 [TBL] [Abstract][Full Text] [Related]
2. DKK3 expression is associated with immunosuppression and poor prognosis in glioblastoma, in contrast to lower-grade gliomas. Han MH; Baek JM; Min KW; Cheong JH; Ryu JI; Won YD; Kwon MJ; Koh SH BMC Neurol; 2023 May; 23(1):183. PubMed ID: 37149563 [TBL] [Abstract][Full Text] [Related]
3. Expression of CD40 Correlates Negatively with Overall and Progression-Free Survival of Low- and High-Grade Gliomas. Werner JM; Kuhl S; Ulrich K; Krischek B; Stavrinou P; Goldbrunner R; Timmer M World Neurosurg; 2019 Oct; 130():e17-e25. PubMed ID: 31125770 [TBL] [Abstract][Full Text] [Related]
4. Identification of potential biomarkers related to glioma survival by gene expression profile analysis. Hsu JB; Chang TH; Lee GA; Lee TY; Chen CY BMC Med Genomics; 2019 Mar; 11(Suppl 7):34. PubMed ID: 30894197 [TBL] [Abstract][Full Text] [Related]
5. Multi-omics landscape of circadian rhythm pathway alterations in Glioma. Zhang C; Xu J; Chen L; Lin X Bioengineered; 2021 Dec; 12(1):3294-3308. PubMed ID: 34224318 [TBL] [Abstract][Full Text] [Related]
6. Revealing transcriptional and post-transcriptional regulatory mechanisms of γ-glutamyl transferase and keratin isoforms as novel cooperative biomarkers in low-grade glioma and glioblastoma multiforme. Mottaghitalab F; Lanjanian H; Masoudi-Nejad A Genomics; 2021 Jul; 113(4):2623-2633. PubMed ID: 34118380 [TBL] [Abstract][Full Text] [Related]
7. NAMPT, GRN, and SERPINE1 signature as predictor of disease progression and survival in gliomas. Vachher M; Arora K; Burman A; Kumar B J Cell Biochem; 2020 Apr; 121(4):3010-3023. PubMed ID: 31710121 [TBL] [Abstract][Full Text] [Related]
8. Comprehensive analysis of histone acetylation-related genes in glioblastoma and lower-grade gliomas: Insights into drug sensitivity, molecular subtypes, immune infiltration, and prognosis. Qin J; Fu J; Chen X J Gene Med; 2024 Mar; 26(3):e3678. PubMed ID: 38500293 [TBL] [Abstract][Full Text] [Related]
9. Low GAS5 Levels as a Predictor of Poor Survival in Patients with Lower-Grade Gliomas. Wang Y; Xin S; Zhang K; Shi R; Bao X J Oncol; 2019; 2019():1785042. PubMed ID: 30853980 [TBL] [Abstract][Full Text] [Related]
10. Integrative Analysis of Neuregulin Family Members-Related Tumor Microenvironment for Predicting the Prognosis in Gliomas. Zhao WJ; Ou GY; Lin WW Front Immunol; 2021; 12():682415. PubMed ID: 34054873 [TBL] [Abstract][Full Text] [Related]
11. Serine Incorporator 2 (SERINC2) Expression Predicts an Unfavorable Prognosis of Low-Grade Glioma (LGG): Evidence from Bioinformatics Analysis. Qi C; Lei L; Hu J; Wang G; Liu J; Ou S J Mol Neurosci; 2020 Oct; 70(10):1521-1532. PubMed ID: 32642801 [TBL] [Abstract][Full Text] [Related]
12. Deregulated expression of the clock genes in gliomas. Chen Z; Liu P; Li C; Luo Y; Chen I; Liang W; Chen X; Feng Y; Xia H; Wang F Technol Cancer Res Treat; 2013 Feb; 12(1):91-7. PubMed ID: 22905804 [TBL] [Abstract][Full Text] [Related]
13. Timing gone awry: distinct tumour suppressive and oncogenic roles of the circadian clock and crosstalk with hypoxia signalling in diverse malignancies. Chang WH; Lai AG J Transl Med; 2019 Apr; 17(1):132. PubMed ID: 31014368 [TBL] [Abstract][Full Text] [Related]
14. Integrating multiple-level molecular data to infer the distinctions between glioblastoma and lower-grade glioma. Zhang X; Lu X; Liu Z; Guan R; Wang J; Kong X; Chen L; Bo C; Tian K; Xu S; Bai M; Zhang H; Li J; Wang L; Shen J; Guo M Int J Cancer; 2019 Aug; 145(4):952-961. PubMed ID: 30694558 [TBL] [Abstract][Full Text] [Related]
15. Exploring the Correlation of Abnormal CXCL9 Expression with Immune Infiltration in Glioma and Patient Prognosis Based on TCGA and GTEx Databases. Liao Y; Liu B; Jin C; Liao X; Zhang Z J Mol Neurosci; 2022 Dec; 72(12):2413-2424. PubMed ID: 36449138 [TBL] [Abstract][Full Text] [Related]
16. Differential Expression of Hypoxia-Related Genes in Primary Brain Tumors and Correlation with Clinicopathologic Data. Bayat S; Mamivand A; Khoshnevisan A; Maghrouni A; Shabani S; Raouf MT; Yaseri M; Saffar H; Tabrizi M World Neurosurg; 2021 Oct; 154():e465-e472. PubMed ID: 34303851 [TBL] [Abstract][Full Text] [Related]
18. [Neuregulin 2 is highly expressed in glioma tissues to regulate glial fibrillary acidic protein expression Zhao W; Lin J Nan Fang Yi Ke Da Xue Xue Bao; 2021 Aug; 41(8):1171-1176. PubMed ID: 34549707 [TBL] [Abstract][Full Text] [Related]
19. Integrative Genomic and Transcriptomic Analysis of Primary Malignant Gliomas Revealed Different Patterns Between Grades and Somatic Mutations Related to Glioblastoma Prognosis. Jin H; Yu Z; Tian T; Shen G; Chen W; Fan M; He Q; Dai D; Zhang X; Liu D Front Mol Biosci; 2022; 9():873042. PubMed ID: 35865002 [No Abstract] [Full Text] [Related]
20. Recurrence- and Malignant Progression-Associated Biomarkers in Low-Grade Gliomas and Their Roles in Immunotherapy. Teng C; Zhu Y; Li Y; Dai L; Pan Z; Wanggou S; Li X Front Immunol; 2022; 13():899710. PubMed ID: 35677036 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]